United Therapeutics | UTHR - Vermögenswerte

Aktienkurs
567.16
Täglich Wechseln
-5.69 -0.99%
Monatlich
4.72%
Jährlich
94.65%
Q2 Prognose
555.02




Vermögenswerte Veränderung Datum
Amarin USD 670.78M 10.96M 2025-12
Ardelyx USD 501.6M 15.43M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Bayer EUR 104.54B 331M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Insmed USD 2.26B 96.18M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
J&J USD 200.89B 1.68B 2026-03
Lexicon Pharmaceuticals USD 184.99M 20.94M 2025-12
Moderna USD 12.34B 203M 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12